| Patents for C40B 30 - Methods of screening libraries (11,320) |
|---|
| 01/05/2012 | US20120004129 Biomarkers for inhibitors with anti-angiogenic activity |
| 01/05/2012 | US20120004128 Fast results hybrid capture assay and associated strategically truncated probes |
| 01/05/2012 | US20120004127 Gene expression markers for colorectal cancer prognosis |
| 01/05/2012 | US20120004126 Efficient Arrays of Amplified Polynucleotides |
| 01/05/2012 | US20120004125 Plant diacylglycerol acyltransferases |
| 01/05/2012 | US20120004124 Markers of regulatory t cell activation |
| 01/05/2012 | US20120004123 Snp-dependent end labeling method |
| 01/05/2012 | US20120004122 Diagnostic Marker for Migraine and Use Thereof |
| 01/05/2012 | US20120004121 Diagnostic Assay For Source of Inflammation |
| 01/05/2012 | US20120004120 Self-encoding sensor with microspheres |
| 01/05/2012 | US20120004119 Gene expression markers of oncolytic virus sensitivity |
| 01/05/2012 | US20120004118 Methods for the subclassification of breast tumours |
| 01/05/2012 | US20120004117 Diagnosis and treatment of cancer using anti-tm4sf20 antibody |
| 01/05/2012 | US20120004116 Methods for biomarker identification and biomarker for non-small cell lung cancer |
| 01/05/2012 | US20120004115 System and method for purification and use of inorganic pyrophosphatase from aquifex aeolicus |
| 01/05/2012 | US20120004112 Methods for determining a breeding value based on a plurality of genetic markers |
| 01/05/2012 | US20120004111 Direct identification and measurement of relative populations of microorganisms with direct dna sequencing and probabilistic methods |
| 01/05/2012 | US20120003629 Biological control of nanoparticle nucleation, shape and crystal phase |
| 01/05/2012 | US20120003246 Novel composition and methods for the treatment of psoriasis |
| 01/05/2012 | US20120003228 Methods for predicting autoimmune disease risk |
| 01/05/2012 | US20120003210 NEONATAL Fc RECEPTOR (FcRn)- BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO |
| 01/05/2012 | US20120003209 Methods and kits used in identifying glioblastoma |
| 01/05/2012 | US20120003181 Novel Retinoid Inducible Factor and Uses Thereof |
| 01/05/2012 | CA2802347A1 Methods of kinome analysis |
| 01/04/2012 | EP2402367A1 Library from toxin mutants, and methods of using same |
| 01/04/2012 | EP2402365A1 Crystal structure of amino terminal portion of influenza virus polymerase pa subunit and use thereof |
| 01/04/2012 | CN102307896A Fibronectin type III domain based scaffold compositions, methods and uses |
| 01/03/2012 | US8088715 Detection of circulating tumor cells in peripheral blood with an automated scanning fluorescence microscope |
| 01/03/2012 | CA2375034C Method and device for analysis of biological specimens |
| 01/03/2012 | CA2337490C Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules |
| 12/29/2011 | WO2011163228A2 Phage-gnrh constructs, their mimics, antigenic compositions, and sequences for immunocontraception of animals and other applications |
| 12/29/2011 | WO2011163214A2 Microrna profiles for evaluating multiple sclerosis |
| 12/29/2011 | WO2011160206A1 Biomarkers for non-hodgkin lymphomas and uses thereof |
| 12/29/2011 | WO2011160189A1 METHOD OF SCREENING FOR INHIBITORS OF sPLA2-IIA |
| 12/29/2011 | US20110321200 Rejuvenation or preservation of germ cells |
| 12/29/2011 | US20110321192 Tomato plants having higher levels of resistance to botrytis |
| 12/29/2011 | US20110319472 Methods of prognosticating and treating ewing sarcoma/pnet and other neoplasms |
| 12/29/2011 | US20110319470 Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |
| 12/29/2011 | US20110319415 Susceptibility to HSP90-Inhibitors |
| 12/29/2011 | US20110319398 Inhibition of yops translocation |
| 12/29/2011 | US20110319295 MASS SPECTROMETRY ASSAY FOR eIF4E AND eIF4E REGULON ACTIVITY |
| 12/29/2011 | US20110319294 Stable, functional chimeric cellobiohydrolase class i enzymes |
| 12/29/2011 | US20110319293 Synthetic protease substrates, assay methods using such substrates and kits for practicing the assay |
| 12/29/2011 | US20110319292 Methods for generating anti-il-23 antibodies, compositions, methods and uses |
| 12/29/2011 | US20110319291 Template fixed beta-hairpin loop mimetics and their use in phage display |
| 12/29/2011 | US20110319290 Methods and Compositions for Multiplex Sequencing |
| 12/29/2011 | US20110319289 Molecular-based method of cancer diagnosis and prognosis |
| 12/29/2011 | US20110319288 Bank1 related snps and sle and/or ms susceptibility |
| 12/29/2011 | US20110319287 Modulator assay |
| 12/29/2011 | US20110319286 System for screening agonists/antagonists of cellular signaling pathways |
| 12/29/2011 | US20110319285 Methods and means for typing a sample comprising colorectal cancer cells |
| 12/29/2011 | US20110319284 Method for determining the predisposition for crohn's disease |
| 12/29/2011 | US20110319283 Oligonucleotides capable of discriminating between nucleic acid sequences that comprise a conserved sequence |
| 12/29/2011 | US20110319282 Methods and kits for the diagnosis and the staging of colorectal cancer |
| 12/29/2011 | US20110319281 Nucleic Acid Analysis by Random Mixtures of Non-Overlapping Fragments |
| 12/29/2011 | US20110319280 Ect2 oncogene as a therapeutic target and prognostic indicator for lung and esophageal cancer |
| 12/29/2011 | US20110319279 Assays Based on Liquid Flow Over Arrays |
| 12/29/2011 | US20110319278 Encoded self-assembling chemical libraries (esachel) |
| 12/29/2011 | US20110319277 Prpk-tprkb modulators and uses thereof |
| 12/29/2011 | US20110319276 Nucleotides and oligonucleotides for nucleic acid sequencing |
| 12/29/2011 | US20110318365 Methods for treatment of degenerative disease associated with apoptosis |
| 12/29/2011 | US20110318347 Amino acid sequences targeting human cd4, cxcr4, ccr5, tlr4, alphav integrin, beta3-integrin, beta1-integrin, human alpha2-integrin, cd81, sr-bi, claudin-1, claudin-6 and claudin-9, respectively, and neutralizing viral entry |
| 12/29/2011 | US20110318344 Tumor Treatment |
| 12/29/2011 | US20110318336 Identification and Treatment of Aggressive Lung Cancer Tumors |
| 12/29/2011 | US20110318269 Method For Screening Phage Display Libraries Against Each Other |
| 12/29/2011 | CA2841142A1 Biomarkers for non-hodgkin lymphomas and uses thereof |
| 12/29/2011 | CA2802738A1 Chronic lymphocytic leukemia modeled in mouse by targeted mir-29 expression |
| 12/29/2011 | CA2801305A1 Detection of nucleic acids and proteins |
| 12/28/2011 | CN102300877A 与糖尿病肾病相关的尿及血清的生物标记 And diabetic nephropathy urine and serum biomarkers |
| 12/28/2011 | CN102300875A 肾病相关的生物标记 Nephropathy biomarkers |
| 12/27/2011 | US8086415 Molecularly imprinted polymer |
| 12/27/2011 | US8084399 Process for screening of a binding amphiphilic peptides specific for hairpin RNA |
| 12/27/2011 | US8083913 Electrochemical cell for testing the electrocatalytic behavior of multiple materials |
| 12/22/2011 | WO2011160042A2 Prpk-tprkb modulators and uses thereof |
| 12/22/2011 | WO2011159959A2 Methods and systems for generating, validating and using monoclonal antibodies |
| 12/22/2011 | WO2011159904A1 Methods for predicting cellular signaling responses to combinatorial stimuli |
| 12/22/2011 | WO2011157448A1 Methods of generating and screening for lytic chimeric polypeptides |
| 12/22/2011 | WO2011127398A3 In vitro cellular bioassay for neurotoxicity testing |
| 12/22/2011 | US20110313029 Diagnostic and therapeutic uses of gnptab, gnptg, and nagpa in stuttering |
| 12/22/2011 | US20110313021 Method to rapidly identify critical p53 target genes that can be utilized for therapeutic intervention |
| 12/22/2011 | US20110312981 Predictive marker for egfr inhibitor treatment |
| 12/22/2011 | US20110312918 Method for identifying agents for inhibiting cell motility and invasiveness |
| 12/22/2011 | US20110312907 Polymorphisms predictive of anthracycline- induced cardiotoxicity |
| 12/22/2011 | US20110312876 Method of determining types I, II, III, IV or V or methicillin-resistant staphylococcus aureus (MRSA) in a biological sample |
| 12/22/2011 | US20110312536 Flow cytometry for high throughput screening |
| 12/22/2011 | US20110312535 Cartridge And Device For Analyzing Biological Samples Using Temperature-Controlled Biological Reactions |
| 12/22/2011 | US20110312534 Method for prediction of human iris color |
| 12/22/2011 | US20110312533 CELL LINES EXPRESSING NaV AND METHODS OF USING THEM |
| 12/22/2011 | US20110312532 Gene Expression Markers for Breast Cancer Prognosis |
| 12/22/2011 | US20110312531 Clinically intelligent diagnostic devices and methods |
| 12/22/2011 | US20110312530 Gene expression signature for classification of tissue of origin of tumor samples |
| 12/22/2011 | US20110312529 Conformational probes and methods for sequencing nucleic acids |
| 12/22/2011 | US20110312528 Novel synergistic combination of gemcitabine with P276-00 or P1446A in treatment of cancer |
| 12/22/2011 | US20110312527 Method of analysing the nucleic acid content of biological fluid |
| 12/22/2011 | US20110312526 Method of analysing the nucleic acid content of a blood sample |
| 12/22/2011 | US20110312525 Soluble icam-1 as biomarker for prediction of therapeutic response |
| 12/22/2011 | US20110312524 Methods employing non-coding rna expression assays |
| 12/22/2011 | US20110312523 Probes, liquid phase chips and methods for detecting pik3ca gene mutations |
| 12/22/2011 | US20110312522 Methods of detection of cancer using peptide profiles |
| 12/22/2011 | US20110312521 Genomic Transcriptional Analysis as a Tool for Identification of Pathogenic Diseases |